Factor | Berge_2006_AppandEnvMic (10249)

10.1128/AEM.02239-05

Antimicrobial Therapy

Cattle | Pre-weaned Calves

11

Description

Group 2 vs Group 3 (see Table 1 for criteria for clinical diagnosis and specific Ams available). Both groups were housed on a calf ranch. Data is from Day 28.

Resistance Outcomes

Resistance Microbe Outcome
Ampicillin
/
Escherichia coli
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 2 (no antimicrobial therapy available) 29 59
Group 3 (antimicrobial therapy available) 30 73
Cefalotin
/
Escherichia coli
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 2 (no antimicrobial therapy available) 8 59
Group 3 (antimicrobial therapy available) 18 73
Ceftiofur
/
Escherichia coli
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 2 (no antimicrobial therapy available) 8 59
Group 3 (antimicrobial therapy available) 18 73
Amikacin
/
Escherichia coli
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 2 (no antimicrobial therapy available) 0 59
Group 3 (antimicrobial therapy available) 3 73
Gentamicin
/
Escherichia coli
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 2 (no antimicrobial therapy available) 13 59
Group 3 (antimicrobial therapy available) 19 73
Streptomycin
/
Escherichia coli
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 2 (no antimicrobial therapy available) 34 59
Group 3 (antimicrobial therapy available) 35 73
Sulfafurazole
/
Escherichia coli
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 2 (no antimicrobial therapy available) 31 59
Group 3 (antimicrobial therapy available) 31 73
Sulfamethoxazole And Trimethoprim
/
Escherichia coli
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 2 (no antimicrobial therapy available) 16 59
Group 3 (antimicrobial therapy available) 20 73
Tetracycline
/
Escherichia coli
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 2 (no antimicrobial therapy available) 34 59
Group 3 (antimicrobial therapy available) 53 73
Chloramphenicol
/
Escherichia coli
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 2 (no antimicrobial therapy available) 6 59
Group 3 (antimicrobial therapy available) 18 73
Nalidixic Acid
/
Escherichia coli
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 2 (no antimicrobial therapy available) 0 59
Group 3 (antimicrobial therapy available) 1 73